about
Staphylococcus aureus and Wegener's granulomatosis.Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approachSafety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosisGenetically distinct subsets within ANCA-associated vasculitisFok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients.Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literatureTwo hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature.TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.Statin use and markers of immunity in the Doetinchem cohort study.DNA extraction from long-term stored urine.Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal diseaseANCA testing in monitoring the activity of the disease.Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamideProteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseasesCoexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?Automatic reading of ANCA-slides: evaluation of the AKLIDES system.Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.Estimating renal survival using the ANCA-associated GN classificationThe relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA?T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?New pathophysiological insights and treatment of ANCA-associated vasculitis.Effects of vitamin D on the peripheral adaptive immune system: a review.Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.Diagnostics and treatment of cryoglobulinaemia: it takes two to tango.Clinical immunology--autoimmunity in the Netherlands.Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications.The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld's syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry.Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study.
P50
Q24805982-DAADA8C4-5072-44D5-AD76-337A35064C45Q28481469-A78B3E31-98AE-4128-87CD-CA07D8880EE6Q28744264-91AA9B07-A356-45AE-8F7D-3B9DEB38200AQ28943363-155556B4-DA58-43AE-A54A-4558E11813A9Q30374618-8D396627-D500-4EA6-B54E-1F1FE0A62C19Q33432784-DC605356-68BB-4E92-81E1-7DAB53CAD72EQ33493067-24870606-DDB5-4E5D-9210-5181DD94BB3DQ33592080-349833FC-13CE-4AEB-93B5-CF332E2E6B4DQ33607277-113DFBF9-2F4F-4929-B00A-75683D7F4CC0Q34581893-930CE6B4-5971-496C-B4ED-CD36C87D319EQ34873853-B52D803D-2446-4928-8972-0945D7812B11Q35023243-EA3B1D08-136D-48C9-B8D0-628E5A760145Q35028030-90753CAE-8C94-4D8B-BE27-C77975DC8379Q35084912-ABD32CE8-121B-4321-BBF2-283973FA108BQ35124231-41AE95F2-0BA9-4ADE-9E3A-1BAF1D0ADBA0Q35540936-DA037468-4325-464B-8EBF-E20D4BDF334AQ35606987-2B0049C1-C42D-4F66-AD6D-098AFC71F0CBQ35851713-75B2E69C-BABE-4568-9A5C-871529C5430DQ35880875-8D5BD10B-6935-4CC9-B649-DCBEB8436DD1Q35953330-224FF900-A063-40F9-8689-CC97BEEA640DQ36104863-F5BC480F-6FD2-4892-B5F8-642E7FC8E3FEQ36154780-9300250B-37E1-48F3-A7B7-BA5A613A38D0Q36235968-14973BCF-4B5B-4852-8C40-1A1F8BB198DDQ36247811-1E812657-6F2F-4AF4-9579-4939BF9AB921Q36410589-D0B97057-0204-45CB-A247-66418A386866Q37031266-E0279774-FC93-40D5-8D8C-BD70BD6D1B3DQ37119908-264F27E4-2B48-4401-A0E7-EC2310165E9EQ37459209-16C198FF-930C-4DCB-951F-297F2CF0BC9AQ37514452-CA69AA0A-FC4A-4407-A46A-307D0F855B7EQ37710764-9DBD3AC7-B03C-4D36-BEAD-F5AD99B6FF3AQ37820047-3A463751-3263-4EB2-A2B2-BAD2722EB7A5Q37881236-8680315D-960B-41F0-BE4B-A027DCEF1367Q37883979-4AB827E0-6AE1-4DE4-A3E1-57C90A0840D4Q38016379-9F09E01A-0C61-4CE9-A315-7C0B2FF42124Q38090840-9F4145A1-01BC-4CCB-A64E-771A40607AD0Q38143718-5F061E75-D6D5-4323-947F-67C9EA86C2FEQ38279509-B0979105-0F39-4BDE-9FE7-D2EDFA160CA7Q38371343-AC816FD4-826A-4C4B-9B5D-77A3D0DEE086Q38663114-4EB36B43-F38B-467E-A35E-74052D6C75B6Q38690327-45780589-3718-438C-A7F4-637FA37EB945
P50
description
Nederlands internist
@nl
researcher ORCID ID = 0000-0001-7407-6364
@en
name
Jan Willem Cohen Tervaert
@ast
Jan Willem Cohen Tervaert
@ca
Jan Willem Cohen Tervaert
@en
Jan Willem Cohen Tervaert
@es
Jan Willem Cohen Tervaert
@fr
Jan Willem Cohen Tervaert
@nl
type
label
Jan Willem Cohen Tervaert
@ast
Jan Willem Cohen Tervaert
@ca
Jan Willem Cohen Tervaert
@en
Jan Willem Cohen Tervaert
@es
Jan Willem Cohen Tervaert
@fr
Jan Willem Cohen Tervaert
@nl
altLabel
J.W.C. Tervaert
@nl
prefLabel
Jan Willem Cohen Tervaert
@ast
Jan Willem Cohen Tervaert
@ca
Jan Willem Cohen Tervaert
@en
Jan Willem Cohen Tervaert
@es
Jan Willem Cohen Tervaert
@fr
Jan Willem Cohen Tervaert
@nl
P106
P1006
P214
P1006
P19
P2038
Jan_willem_Cohen_Tervaert
P21
P213
0000 0003 9362 5749
P214
P31
P3368
P496
0000-0001-7407-6364
P569
1955-04-02T00:00:00Z
P7449
PRS1242387
P7859
viaf-287961346